Indivior Pharmaceuticals (INDV) Receivables Refunds (2021 - 2025)
Historic Receivables Refunds for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $13.0 million.
- Indivior Pharmaceuticals' Receivables Refunds fell 3500.0% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of $33.0 million for FY2024, which is N/A changed from last year.
- Indivior Pharmaceuticals' Receivables Refunds amounted to $13.0 million in Q3 2025, which was down 3500.0% from $3.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Receivables Refunds registered a high of $33.0 million during Q4 2024, and its lowest value of $3.0 million during Q2 2025.
- In the last 5 years, Indivior Pharmaceuticals' Receivables Refunds had a median value of $13.0 million in 2021 and averaged $15.8 million.
- Data for Indivior Pharmaceuticals' Receivables Refunds shows a peak YoY increase of 22222.22% (in 2025) and a maximum YoY decrease of 8636.36% (in 2025) over the last 5 years.
- Over the past 5 years, Indivior Pharmaceuticals' Receivables Refunds (Quarter) stood at $13.0 million in 2021, then tumbled by 61.54% to $5.0 million in 2022, then skyrocketed by 220.0% to $16.0 million in 2023, then surged by 106.25% to $33.0 million in 2024, then plummeted by 60.61% to $13.0 million in 2025.
- Its Receivables Refunds stands at $13.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $29.0 million for Q1 2025.